211
Views
6
CrossRef citations to date
0
Altmetric
Articles

Implementation of HIV pre-exposure prophylaxis for women of color: Perspectives from healthcare providers and staff from three clinical settings

, , , , &
Pages 299-319 | Received 06 Jun 2020, Accepted 03 Feb 2021, Published online: 22 Feb 2021

References

  • Aaron, E., Blum, C., Seidman, D., Hoyt, M. J., Simone, J., Sullivan, M., & Smith, D. K. (2018). Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care and STDs, 32(1), 16–23. https://doi.org/10.1089/apc.2017.0201
  • Adams, L. M., & Balderson, B. H. (2016). HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report. AIDS Care, 28(9), 1154–1158. https://doi.org/10.1080/09540121.2016.1153595
  • Advisory Board. (2020). Where the states stand on medicaid expansion: 36 states, D.C., Have expanded medicaid. Retrieved October 10, 2020, from https://www.advisory.com/daily-briefing/resources/primers/medicaidmap
  • Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV 1. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142
  • Bacon, O., Gonzalez, R., Andrew, E., Potter, M. B., Iñiguez, J. R., Cohen, S. E., Liu, A. Y., & Fuchs, J. D. (2017). Brief report: Informing strategies to build PrEP capacity among San Francisco Bay area clinicians. Journal of Acquired Immune Deficiency Syndromes (1999), 74(2), 175–179. https://doi.org/10.1097/QAI.0000000000001182
  • Baker, G. R. (2011). The contribution of case study research to knowledge of how to improve quality of care. BMJ Quality & Safety, 20(Suppl 1), i30–i35. https://doi.org/10.1136/bmjqs.2010.046490
  • Blackstock, O. J., Patel, V. V., Felsen, U., Park, C., & Jain, S. (2017). Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic. AIDS Care, 29(7), 866–869. https://doi.org/10.1080/09540121.2017.1286287
  • Blumenthal, J., Jain, S., Krakower, D., Sun, X., Young, J., Mayer, K., & Haubrich, R. (2015). Knowledge is power! Increased provider knowledge scores regarding re-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS and Behavior, 19(5), 802–810. https://doi.org/10.1007/s10461-015-0996-z
  • Bokhour, B. G., Saifu, H., Goetz, M. B., Fix, G. M., Burgess, J., Fletcher, M. D., Knapp, H., & Asch, S. M. (2015). The role of evidence and context for implementing a multimodal intervention to increase HIV testing. Implementation Science: IS, 10(1), 22 https://doi.org/10.1186/s13012-015-0214-4
  • Bond, K. T., & Gunn, A. J. (2016). Perceived advantages and disadvantages of using pre-exposure prophylaxis (PrEP) among sexually active black women: An exploratory study. Journal of Black Sexuality and Relationships, 3(1), 1–24. https://doi.org/10.1353/bsr.2016.0019
  • Bush, S., Magnuson, D., & Rawlings, M. K. (2016). Racial characteristics of FTC/TDF for pre-exposure prophylaxis (PrEP) users in the US [Paper presentation]. American Society for Microbiology Annual Meeting June 16–20, 2016, Boston, MA.
  • Calabrese, S. K., Dovidio, J. F., Tekeste, M., Taggart, T., Galvao, R. W., Safon, C. B., Willie, T. C., Caldwell, A., Kaplan, C., & Kershaw, T. S. (2018). HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood. Journal of Acquired Immune Deficiency Syndromes, 79(1), 46–53. https://doi.org/10.1097/QAI.0000000000001762
  • Calabrese, S. K., Magnus, M., Mayer, K. H., Krakower, D. S., Eldahan, A. I., Hawkins, L. A. G., Underhill, K., Hansen, N. B., Kershaw, T. S., Betancourt, J. R., & Dovidio, J. F. (2017). "Support your client at the space that they're in": HIV Pre-Exposure Prophylaxis (PrEP) prescribers' perspectives on PrEP-related risk compensation”. AIDS Patient Care and STDs, 31(4), 196–204. https://doi.org/10.1089/apc.2017.0002
  • Calabrese, S. K., Willie, T. C., Galvao, R. W., Tekeste, M., Dovidio, J. F., Safon, C. B., Blackstock, O., Taggart, T., Kaplan, C., Caldwell, A., & Kershaw, T. S. (2019). Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(4), 395–405. https://doi.org/10.1097/QAI.0000000000002042
  • Centers for Disease Control and Prevention. (2018). HIV surveillance report, (Updated); Vol 31. Retrieved October 10, 2020, from http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • Centers for Disease Control and Prevention. ( 2019). HIV in the United States and dependent areas. Retrieved December 12, 2019, from https://www.cdc.gov/hiv/statistics/overview/ataglance.html
  • Collier, K. L., Colarossi, L. G., & Sanders, K. (2017). Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York City: Community and provider perspectives. Journal of Health Communication, 22(3), 183–189. https://doi.org/10.1080/10810730.2016.1261969
  • Dale, S. K. (2020). Using motivational interviewing to increase PrEP uptake among Black women at risk for HIV: An open pilot trial of MI-PrEP. Journal of Racial and Ethnic Health Disparities, 7(5), 913–927. https://doi.org/10.1007/s40615-020-00715-9
  • Dehlendorf, C., Grumbach, K., Schmittdiel, J., & Steinauer, J. (2017). Shared decision making in contraceptive counseling. Contraception, 95(5), 452–455. https://doi.org/10.1016/j.contraception.2016.12.010
  • Edelstein, Z., Mensah, N., & Scanlin, K. (2014, November 15–19). Awareness of HIV prevention innovations among women of color in NYC: HIV self-tests and pre-exposure prophylaxis (PrEP) [Paper presentation]. American Public Health Association 142nd Annual Meeting and Exposition, New Orleans, LA.
  • Edelstein, Z., Reid, A., & Salcuni, P. (2015, December 6–9). Public health detailing on pre ­. and post­. exposure prophylaxis (PrEP and PEP) in New York City, 2014–2015 [Paper presentation]. National HIV Prevention Conference, Atlanta, GA.
  • Finocchario-Kessler, S., Champassak, S., Hoyt, M. J., Short, W., Chakraborty, R., Weber, S., Levison, J., Phillips, J., Storm, D., & Anderson, J. (2016). Pre-exposure prophylaxis (PrEP) for safer conception among serodifferent couples: Findings from healthcare providers serving patients with HIV in seven US cities. AIDS Patient Care and STDs, 30(3), 125–133. Marhttps://doi.org/10.1089/apc.2015.0268
  • Flash, C. A., Stone, V. E., Mitty, J. A., Mimiaga, M. J., Hall, K. T., Krakower, D., & Mayer, K. H. (2014). Perspectives on HIV prevention among urban black women: A potential role for HIV pre-exposure prophylaxis. AIDS Patient Care and STDs, 28(12), 635–642. https://doi.org/10.1089/apc.2014.0003
  • Fletcher, F. E., Fisher, C., Buchberg, M. K., Floyd, B., Hotton, A., Ehioba, A., & Donenberg, G. (2018). "Where did this [PrEP] come from?" African American mother/daughter perceptions related to adolescent preexposure prophylaxis (PrEP) utilization and clinical trial participation?” Journal of Empirical Research on Human Research Ethics: JERHRE, 13(2), 173–184. https://doi.org/10.1177/1556264618755919
  • Food and Drug Administration. (2019). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Retrieved December 12, 2019, from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.html
  • Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology, 13, 117. https://doi.org/10.1186/1471-2288-13-117
  • Garfinkel, D. B., Alexander, K. A., McDonald-Mosley, R., Willie, T. C., & Decker, M. R. (2017). Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care, 29(6), 751–758. https://doi.org/10.1080/09540121.2016.1234679
  • Goparaju, L., Experton, L. S., Praschan, N. C., Warren-Jeanpiere, L., Young, M. A., & Kassaye, S. (2015). Women want pre-exposure prophylaxis but are advised against it by their HIV-positive counterparts. Journal of AIDS & Clinical Research, 6(11), 1–10. https://doi.org/10.4172/2155-6113.1000522
  • Harvey, G., & Kitson, A. (2016). PARIHS revisited: From heuristic to integrated framework for the successful implementation of knowledge into practice. Implementation Research, 11, 33.
  • Harvey, G., & Kitson, A. eds. (2015). Implementing evidence-based practice in healthcare: A facilitation guide. Routledge.
  • Hirschhorn, L. R., Brown, R. N., Friedman, E. E., Greene, G. J., Bender, A., Christeller, C., Bouris, A., Johnson, A. K., Pickett, J., Modali, L., & Ridgway, J. P. (2020). Black cisgender women's PrEP knowledge, attitudes, preferences, and experience in Chicago. Journal of Acquired Immune Deficiency Syndromes (1999), 84(5), 497–507. Aughttps://doi.org/10.1097/QAI.0000000000002377
  • HIVE. (2019). Family planning provider PrEP Toolkit. Retrieved December 12, 2019, from https://hiveonline.org/prep4familyplanning/
  • Hoffman, S., Guidry, J. A., Collier, K. L., Mantell, J. E., Boccher-Lattimore, D., Kaighobadi, F., & Sandfort, T. G. M. (2016). A clinical home for Preexposure prophylaxis: Diverse health care providers' perspectives on the “purview paradox”. Journal of the International Association of Providers of AIDS Care, 15(1), 59–65. https://doi.org/10.1177/2325957415600798
  • Kaiser Family Foundation. (2020). Medicaid state fact sheets. Retrieved October 10, 2020, from https://www.kff.org/interactive/medicaid-state-fact-sheets/
  • Karris, M. Y., Beekmann, S. E., & Mehta, S. R. (2014). Are We Prepped for pre-exposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. HIV/Aids, 58(5), 704–712.
  • Kitson, A., & Harvey, G. (2016). Methods to succeed in effective knowledge translation in clinical practice. Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing, 48(3), 294–302. https://doi.org/10.1111/jnu.12206
  • Krakower, D. S., Oldenburg, C. E., Mitty, J. A., Wilson, I. B., Kurth, A. E., Maloney, K. M., Gallagher, D., & Mayer, K. H. (2015). Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: Results from a survey of healthcare providers in New England. PLoS One, 10(7), e0132398–15. https://doi.org/10.1371/journal.pone.0132398
  • Krakower, D., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study. AIDS and Behavior, 18(9), 1712–1721. https://doi.org/10.1007/s10461-014-0839-3
  • Kuper, A., Lingard, L., & Levinson, W. (2008). Critically appraising qualitative research. BMJ (Clinical Research Ed.), 337, a1035. https://doi.org/10.1136/bmj.a1035
  • Kwakwa, H. A., Bessias, S., Sturgis, D., Mvula, N., Wahome, R., Coyle, C., & Flanigan, T. P. (2016). Attitudes toward HIV pre-exposure prophylaxis in a United States urban clinic population. AIDS and Behavior, 20(7), 1443–1450. https://doi.org/10.1007/s10461-016-1407-9
  • Laycock, A., Harvey, G., & Percival, N. (2018). Application of the i-PARIHS framework for enhancing understanding of interactive disseminatino to achieve wide-scale improvement in Indigenous primary healthcare. Health Research Policy and Systems, 16(1), 117.
  • Makoul, G., & Clayman, M. (2006). An integrative model of shared decision making in medical encounters. Patient Education and Counseling, 60(3), 301–312. https://doi.org/10.1016/j.pec.2005.06.010
  • Mullins, T. L. K., Zimet, G., Lally, M., & Kahn, J. A. (2016). Adolescent human immunodeficiency virus care providers' attitudes toward the use of oral pre-exposure prophylaxis in youth. AIDS Patient Care and STDs, 30(7), 339–348. https://doi.org/10.1089/apc.2016.0048
  • Mullins, T. L. K., Zimet, G., Lally, M., Xu, J., Thornton, S., & Kahn, J. A. (2017). HIV care providers' intentions to prescribe and actual prescription of pre-exposure prophylaxis to at-risk adolescents and adults. AIDS Patient Care and STDs, 31(12), 504–516. https://doi.org/10.1089/apc.2017.0147
  • Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017). PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256–1267. https://doi.org/10.1007/s10461-016-1625-1
  • Psomas, C., Tuaillon, E., & Marin, G. (2019). Comfort discussing HIV pre-exposure prophylaxis with patients among physicians in an urban emergency department. Journal of Acquired Immune Deficiency Syndromes, 80(2), E49–E52.
  • Ritchie, J., Lewis, J., McNaughton Nicholls, C., & Ormston, R. (2014). Qualitative research practice: A guide for social science students and researchers (2nd ed.). SAGE Publications Ltd.
  • Sales, J. M., & Sheth, A. N. (2019). Associations among perceived HIV risk, behavioral risk and interest in PrEP among black women in the southern US. AIDS and Behavior, 23(7), 1871–1876. https://doi.org/10.1007/s10461-018-2333-9
  • Seidman, D. L., Weber, S., Timoney, M. T., Oza, K. K., Mullins, E., Cohan, D. L., & Wright, R. L. (2016). Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers. Am J Obstet Gynecol, 215(5), 632.e1–e7. https://doi.org/10.1016/j.ajog.2016.06.020
  • Seidman, D., & Weber, S. (2016). Integrating preexposure prophylaxis for human immunodeficiency virus prevention into women's health care in the United States. Obstetrics and Gynecology, 128(1), 37–44. https://doi.org/10.1097/AOG.0000000000001455
  • Seidman, D., Weber, S., Carlson, K., & Witt, J. (2018). Family planning providers' role in offering PrEP to women. Contraception, 97(6), 467–470. https://doi.org/10.1016/j.contraception.2018.01.007
  • Sheth, A. N., Rolle, C. P., & Gandhi, M. (2016). HIV pre-exposure prophylaxis for women. Journal of Virus Eradication, 2(3), 149–155. https://doi.org/10.1016/S2055-6640(20)30458-1
  • Smith, D. K., Mendoza, M. C. B., Stryker, J. E., & Rose, C. E. (2016). PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS One, 11(6), e0156592–2015. https://doi.org/10.1371/journal.pone.0156592
  • Tekeste, M., Hull, S., Dovidio, J. F., Safon, C. B., Blackstock, O., Taggart, T., Kershaw, T. S., Kaplan, C., Caldwell, A., Lane, S. B., & Calabrese, S. K. (2019). Differences in medical mistrust between black and white women: Implications for Patient-Provider Communication About PrEP. AIDS and Behavior, 23(7), 1737–1748. https://doi.org/10.1007/s10461-018-2283-2
  • Terndrup, C., Streed, C. G., Tiberio, P., Black, M., Davis, J., Apfel, A., Blackstock, O. J., Edelman, E. J., & Berkenblit, G. (2019). A cross-sectional survey of internal medicine resident knowledge, attitudes, behaviors, and experiences regarding pre-exposure prophylaxis for HIV infection. Journal of General Internal Medicine, 34(7), 1258–1278. https://doi.org/10.1007/s11606-019-04947-2
  • The Henry, J. (2019). Kaiser Family, Foundation. Women and HIV/AIDS in the United States. Retrieved from December 12, 2019, from https://www.kff.org/hivaids/fact-sheet/women-and-hivaids-in-the-united-states/
  • Tripathi, A., Ogbuanu, C., & Monger, M. (2012). Pre-exposure prophylaxis for HIV infection: Healthcare providers’ knowledge, perception, and willingness to adopt future implementation in the southern US. Southern Medical Journal, 105(4), 199–206.
  • University of Rochester Medical Center. (2019). $2.16M grant funds study of disproportionate hiv infection rates among women of color. Retrieved December 12, 2019, from https://www.urmc.rochester.edu/news/story/5439/2.16m-grant-funds-study-of-disproportionate-hiv-infection-rates-among-women-of-color.aspx
  • Yin, R. (1999). Enhancing the quality of case studies in health services research. Health Services Research, 34(5 Pt 2), 1209–1224.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.